Skip to main content

Table 2 Biochemical and genetic characteristics of patients with PCD

From: Increased detection of primary carnitine deficiency through second-tier newborn genetic screening

No

Gender

NC0 levels (μmol/L)

RC0 levels (μmol/L)

Screened by MassArray assay

Confirmed by NGS

Allele 1

Allele 2

Allele 1

Allele 2

1

Male

1.96

1.73

c.760C > T

c.51C > G

c.760C > T

c.51C > G

2

Female

2.40

1.44

c.760C > T

c.760C > T

c.760C > T

c.760C > T

3

Male

5.78

10.67

c.760C > T

c.797C > T

c.760C > T

c.797C > T

4

Male

5.95

8.64

c.695C > T

NF

c.695C > T

c.1160A > G

5

Female

7.27

6.66

c.760C > T

c.797C > T

c.760C > T

c.797C > T

6

Female

5.58

5.59

c.760C > T

c.1400C > G

c.760C > T

c.1400C > G

7

Female

5.34

6.02

c.797C > T

NF

c.797C > T

c.394-1G > A

8

Female

1.78

1.90

c.695C > T

c.1139C > T

c.695C > T

c.1139C > T

9

Male

4.34

4.45

c.51C > G

c.51C > G

c.51C > G

c.51C > G

10

Female

4.75

4.16

c.760C > T

NF

c.760C > T

c.845G > A

11

Female

3.45

5.24

c.760C > T

c.1400C > G

c.760C > T

c.1400C > G

12

Female

6.82

5.02

c.760C > T

c.1400C > G

c.760C > T

c.1400C > G

13

Male

2.19

2.12

NF

NF

c.822G > A

c.782_799del

14

Male

2.73

9.84

c.51C > G

NF

c.51C > G

c.1144_1162del

15

Male

3.00

10.81

c.51C > G

c.1400C > G

c.51C > G

c.1400C > G

16

Male

6.46

5.10

c.695C > T

c.1400C > G

c.695C > T

c.1400C > G

17

Male

3.02

1.77

c.760C > T

c.760C > T

c.760C > T

c.760C > T

18

Female

6.77

10.05

c.1400C > G

c.1400C > G

c.1400C > G

c.1400C > G

19

Female

2.36

1.75

c.760C > T

c.760C > T

c.760C > T

c.760C > T

20

Female

3.12

2.88

c.760C > T

c.51C > G

c.760C > T

c.51C > G

21

Male

3.64

3.80

c.695C > T

c.1139C > T

c.695C > T

c.1139C > T

22

Female

3.56

4.31

c.760C > T

c.1139C > T

c.760C > T

c.1139C > T

23

Female

6.27

3.43

c.695C > T

c.1139C > T

c.695C > T

c.1139C > T

24

Female

2.70

3.46

c.760C > T

c.51C > G

c.760C > T

c.51C > G

25

Male

7.35

14.27

c.338G > A

c.338G > A

c.338G > A

c.338G > A

  1. NC0: free carnitine detected at newborn screening, RC0: C0 retested at recall stage, cutoff value: 8–50 μmol/L
  2. The novel SLC22A5 variants identified by our team are in boldface type
  3. NF not found